Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363037 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
A Phase 1 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT01363037 is a Phase 1 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 48 participants.
The verdict
NCT01363037, a Phase 1 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and maraviroc vaginal ring and determine whether it is safe when used continuously for 28 days by healthy women in the United States.
Interventions
- DRUG Dapivirine Vaginal Ring
- DRUG Maraviroc Vaginal Ring
- OTHER Placebo Vaginal Ring
- DRUG Dapivirine-Maraviroc Vaginal Ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01363037
The ClinicalTrials.gov registry entry for NCT01363037 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Dapivirine Vaginal Ring is the first listed.
NCT01363037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01363037 about?
NCT01363037 is a clinical study titled "Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring". The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and maraviroc vaginal ring and determine whether it is safe when used continuously for 28 days by healthy women in the United States.
What is the current status of trial NCT01363037?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2011-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01363037?
The interventions under investigation include: Dapivirine Vaginal Ring (DRUG), Maraviroc Vaginal Ring (DRUG), Placebo Vaginal Ring (OTHER), Dapivirine-Maraviroc Vaginal Ring (DRUG).
Who is sponsoring clinical trial NCT01363037?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.